Overview of the Israeli exhibitors at the 2023 HLTH conference in Las Vegas. Exhibitors included 6Degrees, AppScent, Belong.Life, Datos, Expecting, IntraPosition, Kahun Medical, Kemtai, Maverick, Neteera, QuantaIX, Respiration Scan, Nerivio, Xoltar.
40% of Israeli technology investment is devoted to Life Science. Within that domain, the largest sector is Medical Devices and Digital Health (over 65 percent of companies). In the medical device arena, Israeli scientists and engineers have integrated advanced technologies in electronics, communications and electro-optics to develop world-class innovations in Digital Imaging, Medical Lasers, Telemedicine, Early Diagnostics,
Smart Surgical Equipment and more. Over 600 medical device exporters engaged in a variety of medical application
such as Cardiovascular and Peripheral Vascular, Neurology and Degenerative Diseases, Preparedness and Emergency
Medicine, Intensive Care, Women Health, Orthopedics and Sport Medicine, Gastrointestinal, Infection Control, Ophthalmology, Pain and Wound Management, Oral and Dental Care, Dermatology and Aesthetics
Overview of the annual mHealth Israel conference, the largest connected health conference in Israel. Includes two Hackathons, five Meetups across four cities, two Symposia, etc. Register at www.mhealthisrael.com
mHealth Israel_Israeli Digital Health-:An Investors Perspective_Medica Connec...Levi Shapiro
Presentation at Medica, Nov 17, 2015, in the Connected Health Forum. Theme is "Israeli Digital Health- An Investors Persective". Four sections: Ingredients of Israel Success, Israel Venture Industry, Israel Health Sector, Israel Digital Health Investment
Insights on the MedTech Regulatory and Clinical Environment in IsraelGreenlight Guru
Facts about the high-tech industry of Israel
The new medical device law in Israel
The regulatory landscape - requirements and market access
Performing clinical trials in Israel
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Press announcement for Finalists of the 2014 mHealth Israel Startup Contest, to be held on Dec 15th, 2014. Winner will receive likely Round of Funding, courtesy of OurCrowd.
Overview of the annual mHealth Israel conference, the largest connected health conference in Israel. Includes two Hackathons, five Meetups across four cities, two Symposia, etc. Register at www.mhealthisrael.com
mHealth Israel_Israeli Digital Health-:An Investors Perspective_Medica Connec...Levi Shapiro
Presentation at Medica, Nov 17, 2015, in the Connected Health Forum. Theme is "Israeli Digital Health- An Investors Persective". Four sections: Ingredients of Israel Success, Israel Venture Industry, Israel Health Sector, Israel Digital Health Investment
Insights on the MedTech Regulatory and Clinical Environment in IsraelGreenlight Guru
Facts about the high-tech industry of Israel
The new medical device law in Israel
The regulatory landscape - requirements and market access
Performing clinical trials in Israel
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Press announcement for Finalists of the 2014 mHealth Israel Startup Contest, to be held on Dec 15th, 2014. Winner will receive likely Round of Funding, courtesy of OurCrowd.
The third annual mHealth Israel Conference for startups in the digital health technology sector announced seven finalists selected to present at mHealth Israel on February 18.
The Finalists present to a panel of C-level Judges from top global healthcare organizations like Philips, Novartis, AstraZeneca, AARP, etc. Winner receives an all-expenses paid business development trip to Texas for the Medical World Americas Conference, where they will meet with C-level executives from Texas Medical Center and other health systems. The RunnerUp will be invited to present at Medica. The Top 3 will be invited to participate in the Merage Institute program at UC Irvine. The Finalists for the 2016 mHealth Israel Startup Contest are the following: 6over6, Biop Medical, Medaware, Taliaz Diagnostics, Datos Health, Recover.io, Intensix
Setting Up a Multispeciality Hospital Business. Investment Opportunity in Hea...Ajjay Kumar Gupta
Setting Up a Multispeciality Hospital Business. Investment Opportunity in Healthcare Sector. Multispeciality Hospital Business Plan
Humanity is protected by a medical centre or hospital. Aside from that, profit is more critical because it is also a corporation. One of the most important aspects is revenue management, as running a hospital requires a lot of luck. Various hospitals and health care facilities can be found all over us. With the growing number of cases of various illnesses, it is becoming increasingly difficult and unsustainable to keep moving to different locations for different treatments. Many new diseases have arisen as a result of our sedentary lifestyle, and they require multi-specialists to treat.
For More Details:- https://www.entrepreneurindia.co/project-and-profile-details/MULTISPECIALTY%20HOSPITAL
Contact us
Niir Project Consultancy Services
An ISO 9001:2015 Company
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: www.entrepreneurindia.co , www.niir.org
Israel’s Life Science Hub 2023 English Abstract.pdfLevi Shapiro
The war between Israel and Hamas brings its own set of business
challenges. Challenges that may impact how we communicate with
partners and investors abroad. We should portray the life science sector as resilient and adaptable, even in times of crisis. This document is a a messaging outline for Israel's Life Science Hub despite the war with Hamas. Four key points to emphasize:
1) Global activity (resilience and agility)
2) Continuity of care and preventive medicine
3) World leading clinical trials industry
4) Dynamic scientific, research and entrepreneurial ecosystems
The Journal of mHealth, an international publication, has just released their list of “the most innovative and effective companies, from around the world, operating in the mobile, digital and connected care industries today.”
Catalog of Companies_mHealth Israel at AdvaMED 2019Levi Shapiro
Description of Israeli medtech, digital health and connected health startups exhibiting at AdvaMED, the MedTech Conference, 2019. Includes XR Health, Theranica, Oxitone, Bio-T, Fitango, RMDY, RSIP Vision, Gals Bio, Senso Medical, Belkin Laser, MobileODT, Sonivie
How health tech is redefining the future of biopharma and care deliveryΔρ. Γιώργος K. Κασάπης
Tech is making itself felt in every sector of health care. Companies like Google, Apple, Amazon, and Microsoft, and emerging players from the U.S. to China, are poised to transform everything from health care delivery to drug discovery. In this latest eBook STAT has curated a selection of stories that track these developments and examine their impact on hospitals, patients, and the bottom lines of companies around the world.
HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL) goes beyond Big Pharma to track innovative companies worldwide. Here are the top 10 holdings (as of 21 Mar 2019)
MENA’S HEALTH STARTUPS Unlocking the path to scale &
the future of healthcare .
Authors: William Altman, Habib Haddad, Elias Boustani, Kia Davis and Jamil Wyne.
For more information on this report or the Wamda Research Lab please contact research@wamda.com.
10 most reliable cro’s to watch in 2021insightscare
We featured a few trustworthy CROs making a difference in the health space in our latest edition of Insights Care - 10 Most Reliable CROs to Watch in 2021.
mHealth Israel conference_Michel Hivert_MATIMOP_Dec 15, 2014Levi Shapiro
Michel Hivert, CEO of MATIMOP, presents to Israeli digital health community about programs for encouraging exports of Israeli companies to foreign markets, mHealth Israel conference, Dec 15, 2014, Tel Aviv
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The third annual mHealth Israel Conference for startups in the digital health technology sector announced seven finalists selected to present at mHealth Israel on February 18.
The Finalists present to a panel of C-level Judges from top global healthcare organizations like Philips, Novartis, AstraZeneca, AARP, etc. Winner receives an all-expenses paid business development trip to Texas for the Medical World Americas Conference, where they will meet with C-level executives from Texas Medical Center and other health systems. The RunnerUp will be invited to present at Medica. The Top 3 will be invited to participate in the Merage Institute program at UC Irvine. The Finalists for the 2016 mHealth Israel Startup Contest are the following: 6over6, Biop Medical, Medaware, Taliaz Diagnostics, Datos Health, Recover.io, Intensix
Setting Up a Multispeciality Hospital Business. Investment Opportunity in Hea...Ajjay Kumar Gupta
Setting Up a Multispeciality Hospital Business. Investment Opportunity in Healthcare Sector. Multispeciality Hospital Business Plan
Humanity is protected by a medical centre or hospital. Aside from that, profit is more critical because it is also a corporation. One of the most important aspects is revenue management, as running a hospital requires a lot of luck. Various hospitals and health care facilities can be found all over us. With the growing number of cases of various illnesses, it is becoming increasingly difficult and unsustainable to keep moving to different locations for different treatments. Many new diseases have arisen as a result of our sedentary lifestyle, and they require multi-specialists to treat.
For More Details:- https://www.entrepreneurindia.co/project-and-profile-details/MULTISPECIALTY%20HOSPITAL
Contact us
Niir Project Consultancy Services
An ISO 9001:2015 Company
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: www.entrepreneurindia.co , www.niir.org
Israel’s Life Science Hub 2023 English Abstract.pdfLevi Shapiro
The war between Israel and Hamas brings its own set of business
challenges. Challenges that may impact how we communicate with
partners and investors abroad. We should portray the life science sector as resilient and adaptable, even in times of crisis. This document is a a messaging outline for Israel's Life Science Hub despite the war with Hamas. Four key points to emphasize:
1) Global activity (resilience and agility)
2) Continuity of care and preventive medicine
3) World leading clinical trials industry
4) Dynamic scientific, research and entrepreneurial ecosystems
The Journal of mHealth, an international publication, has just released their list of “the most innovative and effective companies, from around the world, operating in the mobile, digital and connected care industries today.”
Catalog of Companies_mHealth Israel at AdvaMED 2019Levi Shapiro
Description of Israeli medtech, digital health and connected health startups exhibiting at AdvaMED, the MedTech Conference, 2019. Includes XR Health, Theranica, Oxitone, Bio-T, Fitango, RMDY, RSIP Vision, Gals Bio, Senso Medical, Belkin Laser, MobileODT, Sonivie
How health tech is redefining the future of biopharma and care deliveryΔρ. Γιώργος K. Κασάπης
Tech is making itself felt in every sector of health care. Companies like Google, Apple, Amazon, and Microsoft, and emerging players from the U.S. to China, are poised to transform everything from health care delivery to drug discovery. In this latest eBook STAT has curated a selection of stories that track these developments and examine their impact on hospitals, patients, and the bottom lines of companies around the world.
HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL) goes beyond Big Pharma to track innovative companies worldwide. Here are the top 10 holdings (as of 21 Mar 2019)
MENA’S HEALTH STARTUPS Unlocking the path to scale &
the future of healthcare .
Authors: William Altman, Habib Haddad, Elias Boustani, Kia Davis and Jamil Wyne.
For more information on this report or the Wamda Research Lab please contact research@wamda.com.
10 most reliable cro’s to watch in 2021insightscare
We featured a few trustworthy CROs making a difference in the health space in our latest edition of Insights Care - 10 Most Reliable CROs to Watch in 2021.
mHealth Israel conference_Michel Hivert_MATIMOP_Dec 15, 2014Levi Shapiro
Michel Hivert, CEO of MATIMOP, presents to Israeli digital health community about programs for encouraging exports of Israeli companies to foreign markets, mHealth Israel conference, Dec 15, 2014, Tel Aviv
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
mHealth Israel_Healthcare Finance and M&A- What Comes NextLevi Shapiro
Healthcare Finance and M&A, What Comes Next? Presentation by Matthew R. Kittay, National Co-Chair, M&A Practice Group, Fox Rothschild LLP. Includes fundraising and investments. Breakouts by subsector- Healthcare (overall), Healthcare services, Digital health, Biopharma, Pharmatech, Medtech, Healthcare IT. Healthcare transaction distribution breakouts. Exits remain flat. Avoiding common legal pitfalls like IP, compliance, governance structure. Current legislation in health law. IP strategy for healthtech.
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...Levi Shapiro
Oppenheimer & Co. Inc, co-Head of Healthcare Investment Banking, Michael Margolis, provides H1 Healthcare Financing, Funding and M&A Overview. Table of Contents
1. Broader Market Overview
2. Biotech M&A Market Overview
3. Private Biotech Financing Market Update
4. Key Advice For Healthcare Companies
Current State of Play; Healthcare has Underperformed the Broader Market Over the Last Twelve Months; Signal-to-Noise is Getting Worse; Healthcare IPO Activity has Decreased Significantly Since 20–21 Pandemic Levels; Biotech Financing Activity Has Remained Robust in 2024; Biotech M&A Market Remains Incredibly Active; Biotech M&A Market Remains Incredibly Active; Big Pharma Upcoming Patent Expirations; Since November 2023 Oncology has accounted for over half of all M&A; Oncology, Autoimmune / I&I, and CV & Metabolic Remain the Top Areas in M&A; Small Molecule Beats Out All Other Modalities in M&A Despite IRA Concerns; Value of Big Pharma Acquisitions by Therapeutic Area in Q1 2024; Private Financing Market Update; 2024 Private Placement Activity On Track to Approach, If Not Exceed, 2020 Levels; Oncology, Particularly Solid Tumor, Continues to Attract VC Investors; Despite the IRA, Small Molecules Continue to Attract VC Dollars; Preclinical-Stage Companies Make Up Almost Half of Private Placements in 2023; Valuations by Development Stage – 2023; Typical Biotech Investors Remained Active in Q1 2024; 23 $100M+ Deals were Raised in Q1 2024; Biotech Fundraising Momentum Continued into 2024; Key Advice For Israeli Healthcare Companies; Although Israel has Strong Presence on US Public Markets, There is Room to Grow; Telling Your Story Effectively; Interacting with Investors to Build Long-term Credibility; Seven Simple Rules for Pitch Decks;
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003Levi Shapiro
Description of the Version Bravo intensive entrepreneurial launch program for 7 Israeli and 7 US former Navy SEALs. Details about each startup concept, the CEOs, the sector, etc.
Radical Life Extension_Dr. Leon Peshkin_Dec 2023Levi Shapiro
Presentation for mHealth Israel by Dr. Leon Peshkin, Harvard Medical School, exploring research into Embryology and Longevity, emphasizing Germline and protein aggregates. Includes current overview, anti aging through history, Lifespan Expansion, ALEC: Animal Life Expectancy in Controls, Scalable Platform in Pharmacobiology, Embryos Cleanse Protein Aggregates, Lysosomal switch triggers proteostasis renewal, Xenopus, Rejuvenation Roadmap, Citizen Science Approach to Aging, Xenopus: Maternal Dowry Molecules, Human Disease Modeling
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...Levi Shapiro
The Future of Digital Health – Nose Dive or Transformation, by Gil Bashe, Dec 4th, 2023 at the mHealth Israel conference. Digital Health Innovation Ecosystem Investment Trends. Data & Methodology. Digital Health Taxonomy. Key Insights for Digital Health Innovation in H1 2023. Global Digital Health Funding Across Regions. Funding in North America. Shifting Focus in North America Digital Health Funding. Investment Focus for Digital Health Venture Funding. Ventures are turning to partnerships for proof points, scale and funding. 2022 new partnerships. North America digital health investor participation. Most active partners in North America. North America Ecosystem Development. Venture distribution by stage. Funding distribution. Comparison to 2022 Funding. Noteworthy deals, noteworthy exits.
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MITLevi Shapiro
We, 465 MIT Alumni, Staff, and Students, are writing to express our deep concern, fear, and disappointment regarding the recent protest that took place Thursday afternoon, in front of the MIT Stratton Student Center. While we fully support the principles of free
speech and the right to peaceful assembly, it is essential that we also prioritize the safety and well-being of all members of the MIT
community.
During the protest, a particular slogan was prominently displayed and chanted, which has raised significant concerns. The slogan
"From the [Jordan] river to the [Mediterranean] sea, Palestine will be free!" has been a source of contention due to its potential
implications and the real safety risks it poses to Jewish and Israeli students on campus [See video footage attached]. This slogan
has been time and again associated with calls for the destruction of the State of Israel and has been used in contexts that
promote violence, which raises legitimate concerns about the safety and security of our Jewish and Israeli students and staff.
Furthermore, we would like to draw your attention to recent events that demonstrate the potential dangers associated with this
slogan. During the 2023 Israel-Hamas war, British Home Secretary Suella Braverman proposed criminalizing the use of the slogan
in certain contexts, recognizing the potential harm it can cause. Additionally, on October 11, ‘23, Vienna police banned a
demonstration, citing the inclusion of the phrase "from the river to the sea" in invitations, as it was seen as a portrayal of a violation
of Article 2 of the European Convention on Human Rights.
In addition to the use of these derogatory messages, several attendees of the event used hateful wordings and messages towards
Jewish and Israeli bystanders. In one case, a perpetrator aggressively held their bicycles as intended to harm a Jewish MIT student,
stating that “[your] ancestors did not die in the Holocaust so they could kill Palestinians” [See video footage attached]. In another
incident, protesters chanted “one solution, intifada revolution”. In the context of the on-going Israeli-Palestinian conflict, the word
"Intifada" means the armed and violent Palestinian insurrection targeting Israelis, including civilians, which resulted in the killing of
thousands of Israelis in the last few decades.
On Oct. 22nd, a statement by MIT CAA (Coalition Against Apartheid) came to our attention. In this document, MIT CCA states that
they "hold the Israeli regime responsible for all unfolding violence". They later call the October 7th terror attack a "response to
the settler colonial regime", and continue justifying it throughout the document.
In this matter, MIT CAA is justifying the heinous and barbaric crimes committed on Oct 7th. Furthermore, these statements have the
potential to fuel acts of aggression
Baptist Health- Engineering the Future of HealthcareLevi Shapiro
Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences.
A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation.
Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals:
Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority
Program built on institutional assets and centers of excellence
Experienced, professional team
Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation.
Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...Levi Shapiro
Presentation by Yael Klionsky, YEDA, for the mHealth Israel community in September, 2023. Title: Challenges in Academic Technology Transfer. Examples-
Transplantation Immunology and Immunometabolism. Efranat Pharma was developing an anticancer immunotherapy treatment based on a natural plasma protein molecule. From target discovery to clinical validation. Clinical-stage drug discovery and development company utilizing a broadly applicable, predictive
computational discovery platforms to identify novel drug targets and new biological pathways and develop
therapeutics in the field of cancer immunotherapy. To allow SOCIETY to benefit from discoveries made at the academic institution. To enable SCIENTISTS to transfer their new technologies to the market. To create an additional source of INCOME for the INSTITUTE so that more independent research can be conducted. Three important elements that make an idea patentable:
1) The invention must be new: the same idea can’t have been
published before in any form; 2) There must be some inventive step of ‘non-obviousness’.
This can be hard to define and depends on the context; 3) The disclosure in a patent must be sufficient for a skilled
person to reproduce the invention with only routine effort; Technology Transfer Company - modus operandi; OUR PURPOSE- To provoke transformative scientific breakthroughs that will shape the future of humanity; SCIENTIFIC STAFF- 300 Principal investigators, >2,000 Research students and PhDs; 5 FACULTIES – BASIC SCIENCE, Biology, Physics, Biochemistry, Math/CS
Chemistry; Generated IP- 57% in Life Science & Biotech; Among the Highest
Income per Researcher
Worldwide; 1959 (First TTO outside the US); Today- More applications per PI than in most Ivy league universities; Copaxone- >$30B
ANNUAL SALES BASED ON Weizmann IP; 20 new licenses per year and 10 new companies per annum; www.yedarnd.com
HADASIT: Tech Transfer and More in Life ScienceLevi Shapiro
Overview of activities in Life Science of Hadasit, the technology transfer arm of Hadassah Hospital in Jerusalem. Includes details about Jerusalem Biodesign program; spinouts like Brainwatch; details about tech transfer (the Secret Engine Behind Israel’s Success); relationship and examples of TTOs enabling Israel's greatest success stories; contrasting of Adademia (Scientific driven research, Creation of new knowledge, Publication, Sharing of Material, Social responsibilities) and Industry (Applied research & specific objectives, Develop new products, Product development, Secrecy and patent protection, Organization responsibilities); Development gap between initial inventions and product development; the Art of translation (from academic research to medical companies); Tech transfer transforms cutting-edge research into marketable healthcare technologies; LICENSING TO EXISTING COMPANIES; SPINNING OFF STARTUPS; CO-DEVELOPMENT OF JOINT IP; Technology Transfer Offices from Academia/Research Hospitals – to Industry; Overview of Hadassah and Hadasit (TECHNOLOGY TRANSFER COMPANY AND INNOVATION ENGINE OF HADASSAH UNIVERSITY HOSPITALS); Examples of “HADASSAH MADE” PRODUCTS IN THE GLOBAL MARKET; RECENT TECH TRANSFER SUCCESS; Example- Lineage Exclusive Worldwide Collaboration with Genentech Opregen® RPE Cell Therapy for the Treatment of Ocular Disorders; HADASIT PILLARS-
NURTURING INTERNAL INNOVATION, Tech Transfer, EXTERNAL INNOVATION. External- SERVICES & COLLABORATIONS WITH COMPANIES, BIOHOUSE FOR STARTUPS, DIGITAL HEALTH ACCELERATOR); Internal Innovation- NURTURING INTERNAL INNOVATION, HADASSAH SEED FUND, JERUSALEM BIODESIGN PROGRAM; TYPES OF RELATIONS WITH EXTERNAL COMPANIES- CONSULTING, SAB, CLINICAL TRIALS, R&D SERVICES, DATA LICENCE, ALPHA/BETA SITE, PILOTS, DESIGN PARTNERSHIPS.
Presenting to Investors & the Media.pdfLevi Shapiro
Presenting to Investors and the Media, lecture by Drew Levinson, LifeSci Communications to mHealth Israel. Three sections: Making a good presentation, Handling
interviews with reporters and Answers that resonate. PRESENTING TO INVESTORS AND THE MEDIA- Compelling delivery, Commanding a room, • Lasting Impact. A good presentation includes Information, Motivation and Excitement. Never put them to sleep. Audience impact includes content, credibility and delivery. Decisions are made leading to potential partnerships, winning business, so much more than a deck, your business, your brand, you. How to captivate begins with storytelling and conversation. More than features- benefits, humanize, positive impact. Don't complicate your message with jargon. Feel the passion- contagious, vision, determination. Know your audience- who are they, what do they know about you, how much do they know, interests, concerns. Articulate your vision- see it, feel it, believe in it. Take them on your journey- compelling narrative, make it personal, why are you doing this, inspiration. Your team- experienced, knowledgeable, aligned, execute. Risks and challenges- recognize, address, plan to mitigate. Test drive your room. What does it look like? Where is the podium? Where will I be standing? Where will you be sitting? Feel comfortable. Three parts to attention. The beginning- attention, interest, what's in it for them, entusiasm, preview. The middle- core, insights, challenges, solutions, relatable. The ending- summary, reinforce, messages, benefits, call to action, keep the momentum going. How to answer questions. The Four R's: repeat, reinforce, refer, remember. Talking to reporters- necessity; Good interview can enhance reputation; Bad interview can tarnish reputation; Preparation is vital. Shapes public opinion: Elevates your brand; Establishes authority; Showcases your business; A bridge; Reputation; Trust; Visibility. Know the reporter. Audience; What have they written; Previous stories; Questions asked. Concise- clear, succinct, engaging. Make it relatable: Stories; Anecdotes; Experiences; Examples; Metaphors; Connect. Honesty and transparency. It is okay not to know every answer. You don’t have to answer every question. Control the narrative. What not to do when talking to reporters. Come up with another way to say no comment. What to wear- solid colors, blues and grays, nothing distracting. Expertise, passion, vision, lasting impression, connections. High stakes, high rewards. Preparation; Know your audience; Deliver with confidence; Enthusiasm; Authenticity. Begin the journey. Engage in dialogue; Build relationships; Inspire trust and confidence; Valued; Enlightened; Motivated and excited.
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...Levi Shapiro
Presentation by Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgical Navigation Company and What's Next for XR. Covers the company founding across multiple milestones and key success factors.
Beyeonics CEO, Ron Schneider, Advances in Medical XRLevi Shapiro
Overview by Beyeonics CEO, Ron Schneider, about the company. Beyeonics One is the first ophthalmic exoscope with an augmented reality surgical headset. It is a high-definition, fully digital imaging platform enabling surgeons to see a magnified, three-dimensional (3D) image of the surgical field. The small footprint, the fast setup, automation, and zero turnover time between procedures all contribute to the efficiency operating rooms strive for. Over 3000 cases to date. Unconstrained Movement. Unconstrained workflow. Data connectivity. Designed for continuous innovation.
XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. Includes a description of the TeleHealth Platform. Lessons Learned – Building the clinical Metaverse. Last mile delivery
Building a product in the Metaverse is easy – getting people to use it is hard. Virtual Care can’t be based only on XR. HMDs bring friction – Charging, Guardian, Safety, Passwords etc. Expanding virtually in a brick & mortar payer environment. Once you cross the chasm – adherence/ satisfaction/retention goes ballistic. Patient Outcomes-
Patients report significant improvement in symptoms following treatment. Adherence - patients follow Home Exercise Plans as prescribed. 92.2% with XRHealth vs 50% with regular treatment. Patient satisfaction - 85 NPS vs 38 NPS in healthcare
93.3% patient retention -complete treatment cycle as prescribed. XRHealth Luna AI Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Virtual reality immersion compared to monitored anesthesia care for hand surgery: A randomized controlled trial. Lessons Learned – Autism Spectrum Disorder. The future of the Mediverse.
Digital Health in US Health Systems.pptxLevi Shapiro
April, 2023 presentation by Gil Bashe, Global Chair, Health Practice, FINN Partners. Insights and analytics, in collaboration with Galen Growth, tracking Digital Health collaboration, adoption, integration, and best practices across the leading US Health Systems. There is a section about focus areas for digital health in health systems and hospitals. The most active health systems are partnering more in diagnosis and have a higher share of digital tools for research. Comprehensive breakout of digital health activities at the Top 10 players: Mayo, Mount Sinai, Cleveland Clinic, Sloan Kettering, Massachusetts General, Northwell, Cedars Sinai, Brigham & Women's, InterMountain. Global breakout of health systems with digital health partnerships at scale. Geographical breakout of digital health partner headquarters (by region). Strong preference for B2B business model. 1/3 of digital health partnerships with Early Stage venture companies. Emphasis is on strong clinical evidence. Portfolio size allows greater diversity. Cluster distribution depends on therapeutic area. Digital health analytics breakout including alpha score, venture similarity score, venture valuation, team signal, partnership signal, evidence signal.
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...Levi Shapiro
Syllabus for the Future of Digital Medicine course, 2023- Biology, Genetics, Technology and BioInformatics. Includes lectures from Noam Shomron, Michal Rosen-Zvi, Eyal Zimlichman, Gila Tolub, Dana Bar-On, Yesha Sivan, Vladi Dvoryis, Varda Shalev, Avi Schroeder, Christian Tidano, Eyal Toledano.
Alagene BioFoundry: Releasing the Genie Out of the Bottle Levi Shapiro
Overview of Israel's leading BioFoundry, Alagene by Roni Cohen, CEO. Overview of Synthetic Biology- Taking biology into engineering mode. Using synthetic genes, to program cells to become factories to make devices, sensors, pharmaceuticals, renewable chemicals, fuels and food. Alagene has four partners with complementary expertise. Hylabs is an established and experienced, highly regulated service company. Reichman University is an academic partner with a commercialization mindset. The Israel Innovation Authority is the government and Aleph VC is an investment firm. Alagene is a home for innovation and R&D center in SynBio, serving as a one-stop—shop for knowledge, methods, and instrumentation to enable our customers in Israel and worldwide to get to their proof of concept. Alagene is anend to end Infrastructure supporting gene & host optimization in microbial systems. The infrastructure enables two Major Implementations- Biomanufacturing and Direct Microbial Application. One example is the development of a Dairy Milk Producing System, using Genetic Optimization and Process Optimization and Validation. Finally, Alagene shared the following recent project examples: Computational prediction for introducing new genes into microbes; Precision fermentation for yeast producing dairy proteins; Bio production of psychoactive / cannabinoid molecule in yeast; Bio production of growth factors for the cultured meat industry; Developing new inhouse tools to support strain optimization; Bio production of egg protein; Computational modeling of full metabolic network in Algae; Bio production of rare sugars with a low glycemic index.
Digital Health Ecosystem- 2022 3rd Quarter ReportLevi Shapiro
Snapshot of the global digital health investment and innovation landscape, Q3 2022, prepared by FINN Partners and Galen Growth. Includes digital health funding history, 2021 digital health investment funding breakouts, winners and losers in 2022 digital health venture funding, global vernture disribution by therapeutic area, venture distribution by stage, regulatory filings by digital health area, change in venture funding by therapeutic area, global digital health funding across regions, top funded therapeutic areas, venture funding in key digital health innovation clusters and geographies, digital health funding across regions, 2022 digital health in Israel, QoQ digital health funding by region, QoQ digital health funding, five year trended digital health funding across regions, noteworthy exits in MENA, M&A, Medigate, Breezometer, AIDOC, Vayyar, Viz.ai, Cathworks, Hello Heart, Israel venture funding and exits
EU Medical Device Regulatory Framework_Dec, 2022Levi Shapiro
Overview of the EU medical technology and digital health regulatory framework by Ulf Grundmann and Elisabeth Kohoutek of King & Spalding LLP. Topics include regulatory scope and definitions, classification and conformity assessment, placing a device on the EU Market, UDI and EUDAMED, Supply Chain Obligations, PMS and Vigilance. MDR covers diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of a disease. ‘Medical Devices’ means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings. The Regulation covers all devices for cleaning, sterilizing or disinfecting other medical devices, reprocessed single-use medical devices, and certain devices with no intended medical purpose.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
2. 2
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents
Intro - Why Israel? 3
The Israel Export & International Cooperation Institute 4
The Foreign Trade Administration 5
Index by Company 6
Index by Categories 9
Index by Therapeutic Areas 12
Companies Profiles 15
3. 3
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
By the end of the 1990s, Israel was home to more than 200 life science companies. With steady growth over the
last decade (some 40 new companies formed each year), Israel has introduced creativity and innovation into the
field; today there are over 1500 active companies.
In a relatively short period of time, an impressive 40 percent of these companies are already generating revenues.
Israel’s entrepreneurial ecosystem creates opportunities for start-ups to become advanced, commercially viable and
promising businesses. As proof of the industry’s development, 2018 Medical Device & Digital Health have passed $2
billion, growing steadily since 2010; while a rich pipeline of seed companies promises to perpetuate current growth.
The Largest Sectors is Medical Devices and Digital Health (over 65 percent of companies). In the medical device
arena, Israeli scientists and engineers have integrated advanced technologies in electronics, communications and
electro-optics to develop world-class innovations in Digital Imaging, Medical Lasers, Telemedicine, Early Diagnostics,
Smart Surgical Equipment and more. Over 600 medical device exporters engaged in a variety of medical application
such as Cardiovascular and Peripheral Vascular, Neurology and Degenerative Diseases, Preparedness and Emergency
Medicine, Intensive Care, Women Health, Orthopedics and Sport Medicine, Gastrointestinal, Infection Control,
Ophthalmology, Pain and Wound Management, Oral and Dental Care, Dermatology and Aesthetics…
The digital era opens tremendous opportunities to deliver healthcare services to patients at the comfort of their
homes or wherever they are, through any web or mobile device, without requiring a presence of healthcare provider
in the loop. For millions of people that live in distance from or in scarcity of healthcare resources and services, the
growing spread of smartphones creates new possibilities to improve healthcare services access and quality of life.
Telemedicine, mHealth, Wearables, Remote Monitoring, Electronic Medical Records, Big Data Analytics, Internet of
Medical Things, Medical Apps and others all can be incorporate into Digital Health or Health Information Technologies.
Israeli Digital Health industry has its roots in a long history of using innovative communication technologies to
improve healthcare delivery. With more than 25 years of expertise in implementing health IT, electronic medical
records and Big Data Analytics; today, our Government keeps investing strongly in IT thus putting Israeli expertise
in international demand.
We are proud of the contributions of our gifted innovators at Israeli Medical Industry, which is a truly rewarding
combination between Life Sciences and High-end Technologies starting from the design, development, advanced
manufacturing integrating innovative materials, systems and technics promoting efficient work of the medical staff,
allowing to achieve maximum accuracy in testing and treatment tailored to each patient’s unique profile • placing
the individual in the center.
Why Israel?
DIVERSITY is the backbone of Israel’s Medical Device & Digital
Health Industry
Diverse Companies • Diverse Technological Implementation • Diverse Medical Applications.
4. 4
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
The Israel Export & International Cooperation Institute, supported by member firms, private sector bodies and the
government of Israel, advances business relationships between Israeli exporters and overseas businesses and
organizations. By providing a wide range of export-oriented services to Israeli companies and complementary
services to the international business community, the Institute helps build successful joint ventures, strategic
alliances and trade partnerships. It has a worldwide business partners at all levels and proven ability to identify
and match suitable potential partners, organize one-on-one business meetings, and is a focal point for contacts
with the government as well as with industry.
The IEICI’s Health Tech Sector is the leader in business matching between more than a 1,000 Israeli companies in
the life science industry and worldwide business partners.
Israel’s life Health Tech industry includes companies targeting all the fields of medicine and offers a variety of
innovative medical solutions and technologies that answer today’s healthcare challenges.
Discover Israel’s Medical Device & Digital Health Industry with IEICI.
Ms. Alona Trivaks
Head of the Health Tech
Israel Export & International Cooperation Institute
+972 3 514 2955 | alonat@export.gov.il
Mr. Ron Pando
Head of HealthTech and Dental
Israel Export & International Cooperation Institute
+972 3 514 2805 | ronp@export.gov.il
Mr. Alberto Spizzichino
Business Development Coordinator, Health Tech
+972 3 514 2878 | albertos@export.gov.il
Israel Inspired by Innovation at HLTH 2023
Booth No. SA.E29
5. 5
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
The Foreign Trade Administration (FTA) is an agency within the Israeli Ministry of Economy and Industry responsible
for promoting and facilitating Israel's international trade activities. Its main objective is to expand Israel's exports,
attract foreign investments, and strengthen economic ties with other countries. The Foreign Trade Administration
operates through more than 50 Economic and Trade Missions worldwide, assisting Israeli businesses in accessing
foreign markets and identifying potential partners and opportunities.
Israel Economic and Trade Mission to the West Coast
The Israel Economic and Trade Mission to the West Coast is the official representation of Israel's economic interests
in the western region of the United States. It serves as a liaison between Israeli businesses and potential partners,
investors, and customers on the West Coast. The Mission focuses on promoting trade and investment opportunities,
fostering innovation and technology collaborations, and strengthening economic ties between Israel and the West
Coast states, such as California, Oregon, and Washington.
Through various events, conferences, and networking opportunities, the Mission aims to facilitate bilateral economic
growth and cooperation in key sectors like technology and AI, cybersecurity, agriculture, health, and more.
Mr. Omer Fein
Economic Consul
Ms. Sarah Benjamin
Head of Healthcare
sarah.benjamin@israeltrade.gov.il
Address: 456 Montgomery St, Suite 1010, San Francisco, CA 94104, USA, Tel. +1 (415) 908-1000
Foreign Trade Administration at the Ministry of Economy
and Industry
6. 6
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Index by Company
Company Name Website Technology Categories Therapeutic Areas Page
6Degrees www.6degrees.tech
Artificial Intelligence Rehabilitation 15
Remote Monitoring
Wearables & IOT
Appscent Medical www.appscent.com Assistive Technologies Diabetics 16
Mobile Healthcare Obesity
Personal Health Assistant Respiratory
Belong.life www.belong.life
Artificial Intelligence Obesity 17
Mobile Healthcare Oncology
Personal Health Assistant Women's Health
Datos Health www.datos-health.com Remote Monitoring Cardiovascular 18
Telemedicine Solutions Internal Medicine
Wearables & IOT Oncology
Expecting www.expecting.ai
Decision Support Systems Gynecology 19
Personal Health Assistant Infertility
Web/Internet Solutions Women's Health
IntraPosition www.intraposition.com
Hospital Operational Efficiency Emergency Medicine 20
Wearables & IOT General Health
Workforce Efficiency Solutions Primary Care
7. 7
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Index by Company
Company Name Website Technology Categories Therapeutic Areas Page
Kahun Medical www.kahun.com Artificial Intelligence Emergency Medicine 21
Decision Support Systems Internal Medicine
Point of Care Diagnostics Primary Care
Kemtai www.kemtai.com Artificial Intelligence General Health 22
Remote Monitoring Orthopedic
Telemedicine Solutions Rehabilitation
Maverick Medical AI www.maverick-ai.com Artificial Intelligence Emergency Medicine 23
Clinical Document Management General Health
Financial Management Primary Care
Neteera US www.neteera.com Precision / Personalized
Medicine
Cardiovascular 24
Remote Monitoring Primary Care
Telemedicine Solutions Respiratory
QuantalX
Neuroscience
www.quantalx.com Point of Care Diagnostics Neurology and
Degenerative Disease
25
Neuroscience
Respiration Scan www.respirationscan.com Artificial Intelligence Intensive Care 26
Decision Support Systems Pulmonary
Point of Care Diagnostics Respiratory
8. 8
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Index by Company
Company Name Website Technology Categories Therapeutic Areas Page
Theranica www.theranica.com Population Health Management General Health 27
Remote Monitoring Neurology and
Degenerative Disease
Wearables & IOT Neuroscience
XOLTAR www.xoltar.com Artificial Intelligence Obesity 28
Medication Adherence Oncology
Personal Health Assistant Women's Health
9. 9
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents by Categories
Artificial Intelligence
6Degrees
Belong.life
Kahun Medical
Kemtai
Maverick Medical AI
Respiration Scan
XOLTAR
Assistive Technologies
Appscent Medical
Clinical Document Management
Maverick Medical AI
Decision Support Systems
Expecting
Kahun Medical
Respiration Scan
Financial Management
Maverick Medical AI
Hospital Operational Efficiency
IntraPosition
10. 10
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents by Categories
Medication Adherence
XOLTAR
Mobile Healthcare
Appscent Medical
Belong.life
Personal Health Assistant
Appscent Medical
Belong.life
Expecting
XOLTAR
Point of Care Diagnostics
Kahun Medical
QuantalX Neuroscience
Respiration Scan
Population Health Management
Theranica
Precision / Personalized Medicine
Neteera US
11. 11
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents by Categories
Remote Monitoring
6Degrees
Datos Health
Kemtai
Neteera US
Theranica
Telemedicine Solutions
Datos Health
Kemtai
Neteera US
Wearables & IOT
6Degrees
Datos Health
IntraPosition
Theranica
Web/Internet Solutions
Expecting
Workforce Efficiency Solutions
IntraPosition
12. 12
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents by Therapeutic Areas
Cardiovascular
Datos Health
Neteera US
Diabetics
Appscent Medical
Emergency Medicine
IntraPosition
Kahun Medical
Maverick Medical AI
General Health
IntraPosition
Kemtai
Maverick Medical AI
Theranica
Gynecology
Expecting
Infertility
Expecting
Intensive Care
Respiration Scan
13. 13
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents by Therapeutic Areas
Internal Medicine
Datos Health
Kahun Medical
Neurology and Degenerative Disease
QuantalX Neuroscience
Theranica
Neuroscience
QuantalX Neuroscience
Theranica
Obesity
Appscent Medical
Belong.life
XOLTAR
Oncology
Belong.life
Datos Health
XOLTAR
Orthopedic
Kemtai
14. 14
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
Contents by Therapeutic Areas
Primary Care
IntraPosition
Kahun Medical
Maverick Medical AI
Neteera US
Pulmonary
Respiration Scan
Rehabilitation
6Degrees
Kemtai
Respiratory
Appscent Medical
Neteera US
Respiration Scan
Women’s Health
Belong.life
Expecting
XOLTAR
15. 15
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.6degrees.tech
6Degrees
Technology Categories
• Artificial Intelligence
• Remote Monitoring
• Wearables & IOT
Therapeutic Areas
• Rehabilitation
Company Status
• Initial Revenues
Enhancing Motion Via Digital Innovation
SOLUTION AT A GLANCE
6Degrees technology was conceived as an adaptable, AI-driven intelligent controller, specifically
designed to understand and learn individual motion capabilities, granting users complete mastery
over various technological aspects. Our advanced analytics capabilities empower users to engage
in their rehabilitation process anywhere, at any moment, and across multiple platforms.
Central to our innovation is the capacity to discern and encapsulate users' inherent abilities,
resulting in a tailored framework of control. Leading to transformative results we enable
individuals to achieve significant milestones right from the outset. Moreover, continuous
monitoring ensures a flexible adaptation to users' changing requirements throughout the course
of their rehabilitation.
Booth No. SA .E36
16. 16
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.appscent.com
Appscent Medical
Technology Categories
• Assistive Technologies
• Mobile Healthcare
• Personal Health Assistant
Therapeutic Areas
• Diabetics
• Obesity
• Respiratory
• Company Status
• Initial Revenues
WORLD’S FIRST CONTACTLESS SLEEP APNEA SOLUTION
SOLUTION AT A GLANCE
INNOVATIVE PATENTED TECHNOLOGY
Our disruptive innovation is a non-invasive, integrated system with a detection and therapeutic
platform.
The detection platform is based on remote sensing technology integrated with AI, local, and cloud-
based back-end. The non-contact sensors capture a range of physiological parameters which are
then analyzed by our advanced AI algorithms that command the remedy platform to act based on
a personalized physiological profile of the user.
Appscent’s breakthrough Scentific medical device offers contactless instant detection and
immediate relief for sleep apnea.
The AI diagnostic platform monitors the patient’s actual breathing and sleep pattern.
Patented scent technology ensures a personalized odorant solution that reduces apnea events
and duration.
Non-contact, non-invasive, effortless, and pleasant bedside solution.
Comfortable and easy handling, simple care, and low maintenance.
Booth No. SA .E36
17. 17
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.belong.life
Belong.life
Technology Categories
• Artificial Intelligence
• Mobile Healthcare
• Personal Health Assistant
Therapeutic Areas
• Obesity
• Oncology
• Women's Health
Company Status
• Revenue Growth
Bringing the power of AI, data and communities to patient engagement and healthcare
SOLUTION AT A GLANCE
Belong.life is a global tech leader, empowering patients and healthcare organizations through end-
to-end patient and professional communities and virtual AI assistants.
Key platforms include the world’s largest social and professional networks for cancer and MS and
the Belong AI Health Mentor app.
Belong’s AI Health Mentor suite of solutions, delivers immediate valuable information proactively
to patients and caregivers.
Trained on billions on de-identified real-world data points, including patient-physician interactions,
anonymized documents, and treatment guidelines, Belong’s conversational AI technology is an
ideal care journey companion, part of Belong's mission to improve the quality of life and care
worldwide.
Booth No. SA .E36
18. 18
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.datos-health.com
Datos Health
Technology Categories
• Remote Monitoring
• Telemedicine Solutions
• Wearables & IOT
• Therapeutic Areas
• Cardiovascular
• Internal Medicine
• Oncology
Company Status
• Revenue Growth
The Datos Health automated remote care platform merges patient monitoring and
engagement
SOLUTION AT A GLANCE
Datos Health’s open platform seamlessly delivers hybrid care across any acuity level or use case.
Clinicians can quickly implement and customize any program, choose the devices that fit their
workflow, and integrate with any EMR. Through our Design Studio, workflows are easily adjusted
by creating remote care programs from scratch or by leveraging existing protocols from leading
healthcare organizations.
These workflows are instantly translated into patient CareApps that collect biometrics and PROMs,
provide self-care guidance and curated content, send escalation alerts to the care team, and
facilitate virtual visits. Workflow automation is now easier than ever for patients and clinicians.
Booth No. SA .E36
19. 19
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.expecting.ai
Expecting
Technology Categories
• Decision Support Systems
• Personal Health Assistant
• Web/Internet Solutions
Therapeutic Areas
• Gynecology
• Infertility
• Women's Health
Company Status
• Seed
Digital Solutions for Expecting Parents: Streamlining Fertility Journeys at Scale
SOLUTION AT A GLANCE
Building a family with the help of a donor or surrogate is an emotional and costly journey.
Expecting streamlines the third-party reproduction process on a grand scale. Combining advanced
digital tools with genuine human touch, we guarantee successful and rewarding experiences for
everyone involved by giving all parties the ability to digitally:
- Simplify and manage the process.
- Connect and match with their ideal partners.
- Find relevant and reliable information.
In 3 years, we're the largest database with 7,000+ egg donors, 300+ surrogates, 90+ providers.
We cut matching time by 30% and cost by 15%. Experience the future of family building with
Expecting.
Booth No. SA .E36
20. 20
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.intraposition.com
IntraPosition
Technology Categories
• Hospital Operational
Efficiency
• Wearables & IOT
• Workforce Efficiency
Solutions
Therapeutic Areas
• Emergency Medicine
• General Health
• Primary Care
Company Status
• Initial Revenues
Streamlining Operations in Healthcare Using Best-in-Class Positioning Tech
SOLUTION AT A GLANCE
IntraPosition streamlines operations in healthcare using best-in-class positioning technology at a
fraction of the cost compared to legacy solutions.
Our real-time location system (RTLS) utilizes proprietary real-time location technology based on
UWB communication.
IntraPosition's solution for healthcare goes beyond mere location tracking. Our system becomes
the hospital’s operations backbone, tackling operational challenges head-on. With our monitoring
and analytics, healthcare professionals are able to optimize the boarding process and patient flow,
track assets accurately, and improve staff communication.
Booth No. SA .E36
21. 21
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.kahun.com
Kahun Medical
Technology Categories
• Artificial Intelligence
• Decision Support Systems
• Point of Care Diagnostics
Therapeutic Areas
• Emergency Medicine
• Internal Medicine
• Primary Care
Company Status
• Seed
Kahun's clinical reasoning engine grounds generative-AI output, enabling it for
clinical use
SOLUTION AT A GLANCE
Kahun’s clinical reasoning engine utilizes a proprietary knowledge graph of over 30 million evidence-
based medical insights to clinically ground generative-AI output, enabling it for clinical use.
Kahun’s clinical reasoning capabilities allow it to serve as the clinical foundation for the use of
Generative AI in healthcare, ensuring transparency, factuality, and consistency in clinical output.
Kahun helps LLMs, health-tech companies and other healthcare organizations to leverage Generative-
AI clinically, delivering trusted clinical solutions to the point of care.
Booth No. SA .E34
22. 22
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.kemtai.com
Kemtai
Technology Categories
• Artificial Intelligence
• Remote Monitoring
• Telemedicine Solutions
Therapeutic Areas
• General Health
• Orthopedic
• Rehabilitation
Company Status
• Seed
Computer Vision Exercise Platform for Physical Therapy & Rehabilitation
SOLUTION AT A GLANCE
Kemtai is a computer vision exercise platform for physiotherapy, MSK and fitness.
It runs on any device with a camera (mobile phones, computers, tablets) it provides patients with
real-time feedback and guidance and provides therapists (or the health services providers) with
the data of the patient's performance in order to further personalize their home exercise protocols.
Booth No. SA .E34
23. 23
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.maverick-ai.com
Maverick Medical AI
Technology Categories
• Artificial Intelligence
• Clinical Document
Management
• Financial Management
Therapeutic Areas
• Emergency Medicine
• General Health
• Primary Care
Company Status
• Revenue Growth
Maverick is revolutionizing Medical Coding with Advanced AI Technologies
SOLUTION AT A GLANCE
Maverick Medical AI revolutionizes the medical coding industry with its cutting-edge, autonomous
platform. The first autonomous coding solution to break the 85% Direct to Bill barrier while
utilizing the power of deep learning AI and the largest database of any solution on the market, it
expertly navigates across diverse medical domains with ease.
Its proprietary deep learning design models and synthetic data generation capabilities offer a
major improvement over standard rule-based and pattern recognition solutions currently available
on the market.
Booth No. SA .E35
24. 24
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.neteera.com
Neteera US
Technology Categories
• Precision / Personalized
Medicine
• Remote Monitoring
• Telemedicine Solutions
Therapeutic Areas
• Cardiovascular
• Primary Care
• Respiratory
Company Status
• Initial Revenues
An FDA-clear contactless RPM platform monitoring heart rate, respiratory rate, and
behavioral parameters
SOLUTION AT A GLANCE
Neteera has developed an FDA-cleared continuous, contactless, passive vital signs and bio-data
monitoring solution. Our platform eliminates the need for device manipulation, removal of clothing,
and caregiver presence.
We enable medical staff to identify patients in need, prioritize those at risk, and use the data to
better understand patient status, improve care, and prevent rehospitalizations.
Booth No. SA .E33
25. 25
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.quantalx.com
QuantalX Neuroscience
Technology Categories
• Point of Care Diagnostics
Therapeutic Areas
• Neurology and Degenerative
Disease
• Neuroscience
Company Status
• Regulatory Approval
Objective Brain Health Diagnosis, at Any Point of Care. Delphi-MD provides functional
visualization and quantitative analysis for the early detection and differential
diagnosis of brain disorders
SOLUTION AT A GLANCE
Delphi-MD shifts the current brain health diagnostic paradigm to improve patient care:
- Early and improved diagnosis at any point of care
- Differential diagnosis for informed, personalized treatment decisions
- Diagnostic value in multiple neurodegenerative diseases
- Radiation free and patient friendly testing
- Instant actionable recommendations report
- Improved risk adjustment
- Reduced stroke hospitalization and rehabilitation costs
- Reduced rate of diagnosis complications and unnecessary surgery
- Reduced costs of dementia homecare, hospitalization and unnecessary CT/ MRI scans
- Higher patient compliance and facilitation of effective treatment pathways
- Improve patient experience and wellbeing
Booth No. SA .E31
26. 26
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.respirationscan.com
Respiration Scan
Technology Categories
• Artificial Intelligence
• Decision Support Systems
• Point of Care Diagnostics
Therapeutic Areas
• Intensive Care
• Pulmonary
• Respiratory
Company Status
• Clinical Trials
Respiration Scan is building the bedrock of breath diagnostics
SOLUTION AT A GLANCE
In 2018, According to the CDC Pneumonia accounted for 47% of hospital-acquired infections in
ventilated ICU patients.
Pneumonia acquired in the ICU is difficult to diagnose; today's methods are lengthy, expensive, and
inaccurate leading to high mortality rates, extended stays, and a financial burden on the system.
RS uses GCMS machines combined with AI to diagnose pneumonia in patients via exhaled breath,
effectively combining cheminformatics and AI to diagnose respiratory disease. Our AI software,
Exhale, finds biomarkers in breath and correlates them to the VOCs captures by the GCMS machine
allowing clinicians to diagnose patients faster than current SOC.
Booth No. SA .E32
27. 27
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.theranica.com
Theranica
Technology Categories
• Population Health
Management
• Remote Monitoring
• Wearables & IOT
Therapeutic Areas
• General Health
• Neurology and Degenerative
Disease
• Neuroscience
Company Status
• Revenue Growth
Nerivio®: a drug-free, FDA-cleared device for migraine treatment and prevention
SOLUTION AT A GLANCE
Theranica develops advanced, clinically proven, safe and affordable digital therapeutics,
addressing some of the world’s most prevalent neurological pain diseases.
Nerivio® is the first and only FDA-cleared device to utilize REN to prevent and treat migraine. Our
technology harnesses pain inhibition through Conditioned Pain Modulation (CPM). CPM is one of
our neural system mechanisms to control pain. Clinical trials demonstrate that Nerivio provides
consistent relief of pain and associated migraine symptoms.
It is safe and well-tolerated with no systemic side effects or concern for medication overuse.
Booth No. SA .E30
28. 28
Contents
Index by Therapeutic Areas
Index by Companies Index by Categories
www.xoltar.com
XOLTAR
Technology Categories
• Artificial Intelligence
• Medication Adherence
• Personal Health Assistant
Therapeutic Areas
• Obesity
• Oncology
• Women's Health
Company Status
• Pre-Seed
XOLTAR builds AI-based accountability partners for behavioral change and adherence
support in patients
SOLUTION AT A GLANCE
The pharmaceutical industry faces a colossal challenge as people, including chronic patients, struggle
to change habits, resulting in a staggering $650 billion annual revenue loss. While the proven solution
of human touch to enhance adherence is limited in scalability, XOLTAR offers a distinct advantage. Our
groundbreaking approach focuses on AI companions, emulating nurse-patient interactions, to provide
unparalleled support for cultivating and sustaining vital, healthy habits in managing medical conditions.
With XOLTAR's innovative AI-based accountability partners, we deliver a scalable, game-changing
solution that revolutionizes patient care, unlocking the full revenue potential for pharma companies.
Booth No. SA .E37